virus
predomin
caus
lower
respiratori
tract
ill
infant
major
caus
hospit
vulner
popul
chapter
review
common
respiratori
viral
agent
infant
young
children
includ
epidemiolog
clinic
radiograph
featur
role
laboratori
diagnosi
emphas
respect
rapid
diagnost
techniqu
histopatholog
featur
tissu
section
brief
summari
major
infantil
respiratori
virus
provid
includ
respiratori
syncyti
viru
parainfluenza
viru
adenoviru
influenza
viru
well
recent
detect
increasingli
signific
lower
respiratori
tract
virus
human
metapneumoviru
coronaviru
rhinoviru
bocaviru
congenit
neonat
form
viral
pneumonia
cytomegaloviru
herp
simplex
viru
measl
viru
also
discuss
postinfecti
complic
viral
bronchiol
includ
chapter
due
signific
persist
morbid
infanc
mani
patient
infantil
respiratori
viral
ill
becom
increas
caus
morbid
mortal
popul
year
age
approxim
pediatr
hospit
admiss
annual
unit
state
estim
hospit
cost
rang
million
annual
tregon
schwarz
coffin
hustedt
vazquez
smut
et
al
lower
respiratori
tract
infect
lrti
lead
indic
hospit
young
children
approxim
lrti
children
viral
contrast
adult
approxim
communityacquir
lrti
viral
etiolog
hammond
et
al
chong
et
al
welliv
common
patholog
virus
infanc
includ
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
adenoviru
adv
influenza
viru
infv
human
metapneumoviru
hmpv
less
coronaviru
cov
rhinoviru
rhv
bocaviru
bov
tregon
schwarz
hammond
et
al
chong
et
al
rsv
remain
preval
sever
neonat
lrti
coffin
hammond
et
al
chong
et
al
chang
et
al
fitzgerald
studi
indic
children
less
year
age
infect
rsv
infect
rate
age
year
tregon
schwarz
hammond
et
al
fitzgerald
johnson
et
al
piv
commonli
occur
within
first
month
life
patient
affect
first
year
life
hammond
et
al
recent
updat
diagnost
technolog
includ
multiplex
polymeras
chain
reaction
pcr
method
offer
accur
faster
diagnost
method
allow
appropri
treatment
patient
manag
importantli
pcr
dna
virus
revers
transcriptas
pcr
rtpcr
rna
virus
also
allow
identif
virus
difficult
cultur
hmpv
bov
allow
better
delin
multiag
respiratori
viral
infect
tregon
schwarz
common
synchron
occur
respiratori
virus
rsv
rhv
tregon
schwarz
chong
et
al
garcia
et
al
last
decad
hmpv
bov
cov
rhv
increasingli
recogn
caus
lower
respiratori
viral
infect
children
hustedt
vazquez
togeth
hmpv
bov
account
approxim
previous
undiagnos
acut
respiratori
infect
hustedt
vazquez
rel
incid
mean
age
diagnosi
infantil
respiratori
viral
infect
unit
state
summar
tabl
known
risk
factor
bronchiol
neonat
includ
prematur
young
age
less
month
low
birth
weight
male
gender
chronic
medic
condit
congenit
heart
diseas
chronic
lung
diseas
due
prematur
trisomi
neuromuscular
disord
cystic
fibrosi
gastroesophag
reflux
immunosuppress
lack
breastfeed
preschool
school
age
sibl
day
care
enrol
tobacco
exposur
lower
socioeconom
statu
crowd
live
condit
tregon
schwarz
coffin
hammond
et
al
welliv
chang
et
al
papenburg
boivin
brodzinski
ruddi
particular
highest
risk
mortal
associ
respiratori
viral
infect
prematur
neonat
less
g
birth
weight
report
mortal
rate
per
live
birth
coffin
mechan
increas
suscept
popul
includ
inadequ
immunolog
defens
infect
possibl
due
lack
immun
experi
diminish
transfer
matern
antibodi
utero
incomplet
develop
neonat
airway
chest
musculatur
decreas
cardiopulmonari
reserv
due
chronic
lung
diseas
hammond
et
al
welliv
papenburg
boivin
chronic
lung
diseas
congenit
heart
diseas
predictor
prolong
hospit
increas
mortal
due
viral
bronchiol
papenburg
boivin
epidemiolog
data
suggest
american
indian
alaskan
nativ
disproportion
higher
mortal
rate
hospit
rate
due
bronchiol
compar
african
american
caucasian
chang
et
al
singleton
et
al
higher
risk
nativ
american
may
due
genet
factor
due
higher
preval
known
matern
risk
factor
includ
diabet
alcohol
tobacco
usag
delay
absent
prenat
care
chang
et
al
singleton
et
al
transmiss
common
lrti
virus
typic
due
exposur
infect
secret
respiratori
droplet
fomit
hand
coffin
fitzgerald
case
neonat
infect
virus
hsv
adv
transmit
via
vagin
deliveri
without
matern
symptom
hammond
et
al
infect
common
virus
correl
season
variat
rsv
infv
hmpv
associ
winter
month
wherea
piv
common
late
spring
summer
month
coffin
hammond
et
al
chong
et
al
garcia
et
al
marco
et
al
mathisen
et
al
common
clinic
sign
symptom
pediatr
lrti
includ
coryza
apnea
rapid
shallow
breath
head
bob
tracheal
tug
chest
wall
hyperinfl
intercost
retract
fitzgerald
addit
small
airway
inflamm
peripher
hyperinfl
within
lung
parenchyma
contribut
symptom
tregon
schwarz
sever
symptom
commonli
character
oxygen
satur
less
hammond
et
al
chang
et
al
fitzgerald
thomson
harri
atyp
clinic
present
virus
difficult
distinguish
bacteri
etiolog
typic
chest
radiograph
demonstr
diffus
airspac
shadow
andor
dispers
area
consolid
bacteri
pneumonia
wherea
viral
pneumonia
often
produc
hyperinfl
lung
parenchyma
patchi
infiltr
peribronchi
cuf
fig
coffin
chong
et
al
howev
much
debat
reproduc
radiograph
diagnosi
pneumonia
concord
radiograph
classif
rel
poor
clinic
util
distinguish
bacteri
versu
viral
etiolog
thomson
harri
one
studi
suggest
specif
infecti
agent
identifi
lrti
leav
clinician
empir
treat
antibiot
potenti
unnecessari
drug
exposur
increas
risk
develop
drug
resist
bacteria
tregon
schwarz
marco
et
al
accur
diagnosi
confirm
viral
etiolog
help
effect
manag
lrti
symptom
noninvas
method
diagnosi
includ
nasal
swab
nasopharyng
aspir
bronchoalveolar
lavag
nasopharyng
aspir
found
sensit
specif
method
superior
nasal
swab
prefer
method
initi
diagnosi
point
care
macfarlan
et
al
nasopharyng
aspir
analyz
direct
immunofluoresc
studi
enzymelink
immunoassay
eia
rtpcr
viral
cultur
coffin
fitzgerald
marco
et
al
cultur
previous
regard
gold
standard
howev
avail
pcr
proven
method
sensit
specif
significantli
faster
process
time
marco
et
al
mathisen
et
al
multiplex
pcr
assay
also
proven
use
lrti
diagnosi
due
simultan
detect
multipl
viral
agent
abil
determin
viral
load
day
result
singl
test
marco
et
al
eia
test
lower
sensit
compar
pcr
techniqu
even
rapid
simplic
commerci
avail
eia
kit
allow
applic
bedsid
yield
result
within
min
particularli
help
tool
peak
season
epidem
papenburg
boivin
tissu
diagnosi
respiratori
viral
infect
also
possibl
via
cytomorpholog
immunohistochemistri
ihc
howev
requir
invas
procedur
infrequ
diagnost
first
step
antibodi
viral
antigen
commerci
avail
immunohistochemistri
neonat
infantil
respiratori
virus
includ
rsv
piv
hmpv
infv
adv
hsv
measl
viru
hammond
et
al
pcr
diagnosi
also
appli
formalinfix
paraffinembed
lung
tissu
akhtar
et
al
tabl
compar
variou
diagnost
method
util
pathogenesi
symptom
relat
lower
respiratori
tract
viral
infect
infant
primarili
narrow
occlus
conduct
airway
lead
reduc
ga
exchang
respiratori
distress
hammond
et
al
combin
direct
viral
injuri
epithelium
immunolog
damag
respons
patholog
chang
exacerb
underdevelop
immun
immatur
airway
tregon
schwarz
coffin
histolog
respiratori
virus
typic
caus
pattern
lymphocyt
bronchiol
without
interstiti
pneumon
lymphocyt
bronchiol
recogn
presenc
circumferenti
cuff
airwaycent
lymphocyt
macrophag
case
associ
secondari
epitheli
necrosi
slough
plug
bronchiol
fibrin
mucu
squamou
metaplasia
bronchiolar
epithelium
surround
airspac
may
promin
heal
phase
injuri
interstiti
lymphocyt
inflammatori
infiltr
pneumon
may
present
despit
fact
direct
viral
infect
type
type
pneumocyt
variabl
demonstr
coffin
hammond
et
al
welliv
specif
viral
cytopath
effect
typic
recogniz
congenit
hsv
adv
infect
viral
cytopath
effect
rare
absent
respiratori
viral
infect
infant
includ
rsv
hmpv
piv
infv
contrast
otherwis
healthi
children
immunosuppress
neonat
infant
eg
patient
bone
marrow
transplant
solid
organ
transplant
human
immunodefici
viru
infect
primari
immunodefici
typic
less
inflammatori
respons
florid
viral
cytopath
effect
similar
seen
pure
cultur
media
multinucl
syncyti
giant
cell
cytoplasm
inclus
suggest
diagnosi
rsv
hmpv
piv
immunohistochemistri
molecular
test
tissu
would
necessari
confirm
diagnosi
viru
detect
previous
rsv
infect
common
caus
upper
lower
respiratori
tract
infect
children
seropreval
approach
popul
year
age
papenburg
boivin
peak
incid
week
month
age
hustedt
vazquez
clinic
rsv
infect
upper
respiratori
tract
caus
coryza
cough
hoars
rhiniti
conjunct
acut
otiti
media
frequent
complic
lower
respiratori
tract
infect
due
rsv
result
syndrom
bronchiol
pneumonia
less
commonli
croup
asthma
exacerb
william
et
al
vomit
seen
signific
percentag
children
hospit
requir
infect
infant
mortal
rel
rare
account
approxim
death
annual
unit
state
hustedt
vazquez
hammond
et
al
histopatholog
find
rsv
infect
includ
circumferenti
inflamm
bronchiolar
mucosa
infect
type
pneumocyt
fig
johnson
et
al
inflammatori
infiltr
consist
bronchocentr
mucos
transmur
mononuclear
cell
primarili
lymphocyt
monocyt
neutrophil
neutrophil
infiltr
center
bronchiol
wherea
mononuclear
infiltr
affect
bronchiol
parenchyma
virus
airway
obstruct
result
epitheli
inflammatori
cell
debri
mix
fibrin
mucu
edema
compound
extrins
compress
bronchiol
hyperplast
lymphoid
follicl
johnson
et
al
syncyti
giant
cell
format
rare
immunocompet
children
characterist
histopatholog
featur
immunocompromis
patient
fig
coffin
hammond
et
al
welliv
therapi
rsv
includ
use
ribavirin
synthet
nucleosid
analogu
highrisk
popul
children
may
also
prevent
treat
palivizumab
monoclon
antibodi
target
f
protein
rsv
papenburg
boivin
first
identifi
hmpv
recogn
import
common
caus
respiratori
viral
infect
infant
account
approxim
acut
respiratori
infect
previous
healthi
young
children
cultureneg
viral
infect
popul
hustedt
vazquez
william
et
al
specif
hmpv
caus
acut
bronchiol
young
children
kahn
approxim
hmpv
infect
occur
infant
less
year
age
age
diagnosi
tend
slightli
older
infant
rsv
infect
seropreval
approach
popul
year
age
contrast
year
age
rsv
papenburg
boivin
brodzinski
ruddi
case
diagnos
decemb
april
peak
incid
march
clinic
hmpv
caus
symptom
gener
similar
rsv
infect
includ
cough
coryza
rhiniti
major
patient
clinic
diagnos
associ
hmpv
includ
bronchiol
croup
asthma
exacerb
pneumonia
william
et
al
acut
otiti
media
also
common
brodzinski
ruddi
like
rsv
wheez
prolong
expir
hypoxemia
common
featur
wolf
et
al
studi
shown
less
sever
diseas
rsv
indic
shorter
durat
symptom
less
frequent
oxygen
requir
less
frequent
respiratori
support
intens
care
admiss
papenburg
boivin
hospit
hmpv
infect
often
associ
underli
medic
condit
compar
rsv
infect
vs
william
fatal
hmpv
infect
describ
immunocompromis
patient
william
enzymelink
assay
method
avail
rapid
diagnosi
hmpv
molecular
method
rtpcr
use
definit
diagnosi
viral
cytopath
effect
identifi
cultur
less
half
case
typic
take
week
develop
contrast
rsv
typic
demonstr
characterist
syncyti
giant
cell
cytopath
effect
day
papenburg
boivin
william
et
al
viral
cultur
hmpv
also
requir
special
condit
includ
specif
cell
line
trypsin
supplement
brodzinski
ruddi
coinfect
second
viru
rsv
occur
least
patient
hmpv
studi
hmpv
infect
brodzinski
ruddi
rsv
bronchiol
hmpv
coinfect
suggest
produc
sever
diseas
although
support
studi
fouchier
et
al
base
anim
studi
hmpv
appear
directli
infect
bronchial
bronchiolar
respiratori
epithelium
associ
peribronchiolar
mononuclear
infiltr
intralumin
collect
mononuclear
cell
neutrophil
hammond
et
al
lavag
specimen
find
includ
respiratori
epitheli
cell
degener
andor
necrosi
ciliocytophthoria
round
eosinophil
cytoplasm
inclus
similar
seen
rsv
piv
measl
infect
background
hemosiderinladen
macrophag
abund
neutrophil
promin
mucu
also
note
hammond
et
al
varga
et
al
acut
organ
lung
injuri
diffus
alveolar
damag
report
papenburg
boivin
current
approv
vaccin
specif
antivir
therapi
hmpv
clinic
piv
caus
clinic
syndrom
croup
laryngotrach
major
patient
less
common
manifest
includ
bronchiol
pneumonia
asthma
exacerb
william
et
al
four
serotyp
parainfluenza
viru
season
highest
preval
fall
month
unit
state
wherea
occur
yearround
peak
late
spring
summer
bronchiol
pneumonia
typic
seen
young
infant
less
month
age
wherea
often
caus
upper
respiratori
tract
diseas
toddler
young
children
year
age
often
asymptomat
infrequ
detect
mortal
piv
quit
low
except
overwhelm
infect
immunocompromis
patient
histopatholog
featur
gener
popul
well
describ
anim
model
piv
infect
demonstr
infect
bronchiolar
epithelium
bronchiol
pneumon
hammond
et
al
histolog
piv
produc
giant
cell
pneumon
occasion
cytoplasm
inclus
immunocompromis
host
histolog
indistinguish
rsv
metapneumoviru
infect
fig
clinic
adenoviru
associ
sever
differ
syndrom
includ
keratoconjunct
gastroenter
diarrhea
cystiti
respiratori
tract
diseas
respiratori
tract
adenoviru
associ
often
bronchiol
croup
symptom
less
often
pneumonia
asthma
exacerb
william
et
al
communityacquir
infect
spread
respiratori
droplet
although
neonat
infect
may
follow
vagin
deliveri
infect
mother
often
associ
prolong
ruptur
membran
hammond
et
al
sever
adv
infect
caus
necrosi
destruct
bronchial
bronchiolar
epithelium
well
adjac
parenchym
necrosi
parenchym
necrosi
may
widespread
immunocompromis
patient
adv
carri
particularli
high
mortal
popul
due
dissemin
diseas
within
respiratori
alveolartyp
epithelium
nuclear
inclus
appear
diffus
amphophil
materi
peripher
chromatin
smudg
cell
less
commonli
eosinophil
central
nuclear
inclus
peripher
halo
similar
seen
cowdri
herp
simplex
viru
inclus
hammond
et
al
postinfecti
oblit
bronchiol
bronchiol
obliteran
syndrom
common
sequela
neonat
immunocompromis
patient
due
sever
bronchiolar
mucos
necrosi
caus
adenoviru
influenza
viru
clinic
may
caus
fever
vomit
conjunct
croup
symptom
bronchiol
pneumonia
william
et
al
contrast
hmpv
asthma
exacerb
typic
featur
infv
infect
infv
occur
individu
across
broad
age
rang
period
region
epidem
occasion
part
major
global
pandem
influenza
outbreak
peak
incid
winter
month
unit
state
may
induc
sever
diseas
young
infant
elderli
immunocompromis
popul
viru
primarili
infect
bronchial
bronchiolar
respiratori
epithelium
occasion
alveolar
epitheli
cell
also
demonstr
immunohistochemistri
classic
infv
infect
produc
necrot
bronchiol
peribronchiolar
infiltr
interstiti
inflamm
pulmonari
edema
hyalin
membran
diffus
alveolar
damag
fig
secondari
bacteri
pneumonia
common
fatal
case
bhat
et
al
guarner
et
al
current
four
antivir
effect
infv
infect
amantidin
rimantadin
anamivir
oseltamivir
vaccin
recommend
infant
greater
month
old
pregnant
women
protect
neonat
first
month
life
passiv
immun
bocaviru
recent
identifi
viral
agent
pediatr
airway
discov
identifi
approxim
previous
undiagnos
respiratori
viral
infect
children
seropreval
studi
almost
children
expos
bov
year
age
averag
age
diagnosi
month
hustedt
vazquez
true
role
bov
caus
agent
respiratori
infect
controversi
due
high
rate
viral
coinfect
milder
arnold
hmpv
andor
bov
identifi
half
viral
coinfect
children
hustedt
vazquez
nevertheless
avail
studi
control
shown
asymptomat
patient
detect
bov
lend
credenc
bov
true
pathogen
children
brieu
et
al
similar
pediatr
respiratori
viral
infect
symptom
bov
includ
fever
rhinorrhea
cough
sore
throat
wheez
furthermor
bov
identifi
patient
gastroenter
potenti
caus
kawasaki
diseas
brodzinski
ruddi
peak
incid
bov
winter
month
similar
rsv
hmpv
laboratori
diagnosi
made
eia
method
pcr
technolog
mainstay
treatment
support
care
avail
medic
therapi
time
coronavirus
long
appreci
signific
caus
mild
upper
respiratori
tract
infect
cov
type
rel
recent
appreci
occasion
caus
lower
respiratori
tract
infect
children
canducci
et
al
follow
sever
acut
respiratori
syndrom
sar
epidem
increas
attent
coronavirida
famili
virus
reveal
new
variant
discov
netherland
hcov
anoth
variant
discov
hong
kong
hcov
caus
pediatr
bronchiol
pneumonia
brodzinski
ruddi
cov
detect
approxim
upper
lower
respiratori
tract
infect
children
approxim
specimen
young
children
viral
ill
acut
wheez
smut
et
al
cov
difficult
isol
cell
cultur
molecular
method
often
use
laboratori
detect
kahn
cov
identifi
yearround
although
season
peak
describ
januari
march
smut
et
al
brodzinski
ruddi
rhinoviru
picornaviru
often
recogn
caus
common
cold
rhiniti
increasingli
recogn
caus
lower
respiratori
tract
viral
infect
age
base
upon
molecular
detect
method
atmar
et
al
infant
peak
age
infect
report
month
peak
season
fall
spring
fetus
neonat
cytomegaloviru
infect
may
acquir
vertic
pregnanc
cmv
infect
also
may
latent
emerg
opportunist
infect
immunocompromis
patient
immunocompromis
patient
clinic
diagnosi
cmv
pneumonia
requir
detect
viru
respiratori
sampl
also
presenc
respiratori
symptomatolog
congenit
cmv
infect
manifest
dissemin
diseas
frequent
viral
cytopath
effect
classic
induc
cytomegali
larg
intranuclear
inclus
peripher
halo
small
granular
basophil
cytoplasm
inclus
cmv
pneumon
may
associ
lymphoplasmacyt
inflamm
alveolar
wall
herp
simplex
viru
pneumonia
typic
occur
congenit
infect
newborn
often
acquir
infect
cervicovagin
secret
vagin
deliveri
follow
typic
incub
period
day
skin
lesion
liver
failur
detect
altern
neonat
infect
may
acquir
infect
oral
secret
parent
caregiv
intrauterin
infect
matern
viremia
rare
clinic
present
typic
unsuspect
fulmin
requir
rapid
diagnosi
treatment
mortal
high
set
dissemin
diseas
morbid
surviv
neonat
follow
enceph
may
includ
seizur
spastic
blind
learn
disabl
congenit
hsv
infect
regrett
difficult
predict
prevent
herpet
vesicl
may
appar
infect
mother
histolog
featur
regardless
organ
involv
character
punctat
area
necrosi
surround
rim
cell
characterist
intranuclear
viral
cytopath
effect
cowdri
cowdri
b
type
inclus
fig
measl
viru
pneumonia
rare
unit
state
due
vaccin
program
common
develop
countri
young
infant
yet
schedul
vaccin
suscept
primari
infect
greatest
risk
sever
fatal
diseas
hammond
et
al
immunocompromis
host
measl
viru
infect
classic
result
giant
cell
pneumon
compos
interstiti
pneumonia
larg
multinucl
syncyti
giant
cell
line
airspac
giant
cell
may
intracytoplasm
globular
eosinophil
inclus
reflect
aggreg
cytoplasm
rna
viru
diffus
alveolar
damag
squamou
metaplasia
variabl
featur
radoycich
et
al
immunocompet
children
necrot
bronchiol
note
giant
cell
typic
spars
cytoplasm
inclus
appar
radoycich
et
al
postinfecti
reactiv
airway
diseaseasthma
follow
acut
infect
virus
caus
chronic
sequela
postinfecti
recurr
wheez
rsv
hmpv
rhv
patient
sever
rsv
bronchiol
associ
increas
risk
hospit
asthma
short
term
papenburg
boivin
suggest
greater
sever
rsv
bronchiol
may
reflect
intrins
genet
predisposit
asthma
hmpv
detect
approxim
children
recurr
wheez
bov
approxim
smut
et
al
specif
hmpv
bronchiol
carri
fivefold
risk
futur
develop
asthma
compar
control
patient
hospit
gastroenter
brodzinski
ruddi
postinfecti
bronchiol
obliteran
syndrom
oblit
bronchiol
bronchiectasi
may
follow
form
necrot
bronchiol
often
report
sequela
adv
infect
tregon
schwarz
coffin
hammond
et
al
chong
et
al
garcia
et
al
chang
et
al
clinic
postinfecti
bronchiol
obliteran
syndrom
character
obstruct
pulmonari
function
test
chest
ct
evid
bronchiectasi
region
air
trap
mosaic
perfus
best
seen
expiratori
imag
histolog
oblit
bronchiol
character
fibrou
obliter
constrict
small
airway
subepitheli
fibrosi
fig
find
may
subtl
subject
sampl
error
wedg
lung
biopsi
connect
tissu
stain
trichrom
movat
pentachrom
help
elicit
fibrot
airway
within
bronchovascular
bundl
respiratori
viral
infect
infant
differ
seen
adult
neonat
infant
predispos
rsv
hmpv
piv
contrast
rhv
cov
infv
common
lower
respiratori
tract
virus
adult
prematur
infant
particularli
suscept
viral
infect
carri
higher
morbid
mortal
rel
adult
popul
laboratori
diagnosi
viral
cultur
eia
multiplex
pcr
assay
mainstay
specif
diagnosi
infanc
similar
older
children
adult
despit
increasingli
recogn
preval
cultureneg
respiratori
virus
hmpv
bov
cov
rsv
remain
central
pathogen
respiratori
infect
infant
tend
sever
virus
patholog
featur
lung
biopsi
autopsi
vari
depend
immunolog
statu
patient
immunocompromis
infant
pronounc
viral
cytopath
effect
giant
cell
andor
viral
inclus
rel
littl
inflammatori
respons
wherea
otherwis
healthi
infant
often
lymphocyt
bronchiol
pneumon
without
distinguish
viral
cytopath
effect
immunohistochemistri
may
use
confirm
diagnosi
tissu
howev
costeffect
comprehens
method
confirm
diagnosi
current
use
molecular
diagnost
techniqu
